Alzheimer’s Drug Shrinks Brain Volume by Removing Amyloid Plaques
Summary: Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques ...
Tag: Alzheimers
Alzheimer’s Drug Faces Scrutiny Over Safety, Efficacy Concerns
Summary: The FDA-approved Alzheimer’s drug donanemab is under scrutiny due to concerns about its effectiveness and safety, according to an ...
AI Predicts Alzheimer’s Progression – Neuroscience News
AI Predicts Alzheimer’s Progression Neuroscience NewsArtificial intelligence outperforms clinical tests at predicting progress of Alzheimer's disease Medical XpressCan We Predict the Speed ...
FDA Panel Backs Donanemab: New Hope for Early Alzheimer’s Treatment
Summary: An independent panel has recommended that Eli Lilly’s Alzheimer’s drug, Donanemab, be approved by the FDA. The drug has ...
tRNA Fragments Linked to Alzheimer’s
Summary: A new study identifies a crucial factor in brain aging and Alzheimer’s disease—the accumulation of Glu-5’tsRNA-CTC in neuron mitochondria. ...
Light Therapy Shines in Treating Alzheimer’s Sleep and Mood Issues
Summary: A new study highlights the efficacy of light therapy in enhancing sleep and reducing psycho-behavioral symptoms in Alzheimer’s patients. ...
Alzheimer’s Affects Brain Networks Beyond Memory
Summary: Researchers discovered that Alzheimer’s-related changes in brain networks extend beyond memory and attention, impacting sensory and motor circuits. These ...
From COVID Cough to Cognitive Concerns: Unraveling the Alzheimer’s Link
By Wiley October 22, 2023Research suggests that neurological symptoms observed in COVID-19 patients could indicate an increased risk of neurodegeneration, ...
Harnessing Nature’s Sweetness to Fight Alzheimer’s
Phyllodulcin, a natural sweetener found in Hydrangea macrophylla var. thunbergii, shows potential for treating Alzheimer's disease (AD). The study demonstrates ...
MIT Scientists Shed Light on Alzheimer’s Disease
MIT researchers have found that the Tau protein, linked to neurodegenerative diseases, forms harmful filaments more easily when its ends ...